Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Censoring Survival Data01:09

Censoring Survival Data

Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different reasons...
Longitudinal Studies01:26

Longitudinal Studies

Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toward Evidence Synthesis of Adverse Events in Imbalanced Time-to-Event Data.

Journal of evidence-based medicine·2026
Same author

Gut microbial bile salt hydrolase as a metabolic gatekeeper in digestive homeostasis and disease.

Frontiers in immunology·2026
Same author

Trial-design-aware funnel plot for publication bias assessment with non-inferiority or equivalence objectives.

Journal of clinical epidemiology·2026
Same author

Unpublished trials affected evidence synthesis substantially when estimating medication harms in children.

Journal of clinical epidemiology·2026
Same author

The hazards of using hazard ratios from proportional hazard models in indirect treatment comparisons.

Research synthesis methods·2026
Same author

Minimum distance estimation of mean and standard deviation from reported quantiles.

Research synthesis methods·2026
Same journal

Biology Over Monotherapy: Mature Results From European Organisation For Research and Treatment of Cancer 22033-26033 Reaffirm Molecular Stratification, Not Treatment Sequence, Defines Prognosis in Low-Grade Glioma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Efficacy and Tolerability of Zenocutuzumab in Advanced <i>NRG1</i> Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.2.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
See all related articles

Related Experiment Video

Updated: May 21, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Missing data in clinical studies: issues and methods.

Joseph G Ibrahim1, Haitao Chu, Ming-Hui Chen

  • 1Department of Biostatistics, University of North Carolina, CB # 7420, Chapel Hill, NC 27599, USA. ibrahim@bios.unc.edu

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|June 1, 2012
PubMed
Summary
This summary is machine-generated.

Missing data in studies can lead to inaccurate results if participants are excluded. This analysis explores methods to properly handle missing data in various statistical models, ensuring reliable conclusions.

Related Experiment Videos

Last Updated: May 21, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Data Analysis

Background:

  • Missing data is a common challenge in statistical analyses across various research fields.
  • Incomplete participant data can compromise the integrity of study outcomes and conclusions.
  • Commonly employed methods like complete case analysis can introduce bias.

Purpose of the Study:

  • To discuss the challenges and implications of missing data in statistical analyses.
  • To explore various classifications and types of missing data.
  • To demonstrate the limitations of excluding participants with missing data.

Main Methods:

  • Review of statistical methods for handling missing data in generalized linear models, longitudinal data models (e.g., generalized linear mixed effects models), and Cox regression models.
  • Discussion of different missing data classifications.
  • Application of methods to real-world clinical trial data.

Main Results:

  • Excluding participants with any missing data can lead to incorrect results and conclusions.
  • Appropriate methods for handling missing data are crucial for valid statistical inference.
  • The discussed methods are applicable to discrete, continuous, and time-to-event endpoints.

Conclusions:

  • Standard methods of excluding participants with missing data are often inadequate and can yield biased results.
  • Proper statistical techniques are essential for accurate analysis of studies with missing data.
  • The principles discussed are broadly applicable beyond cancer research to any study encountering missing data.